Table 1 Patient/tumor characteristics from the BR9601 trial and samples retrieved for the current study
BR9601 | TIMP-1 Analysis | |
|---|---|---|
Number | 374 | 288 |
Age | 50.9 (44.7 to 56.6) | 50.5 (45.0 to 57.0) |
E-CMF (1) | 183 (48.9%) | 140 (48.6%) |
CMF (2) | 191 (51.1%) | 148 (51.4%) |
Tumor size (median) | 23 (17 to 30) | 25 (17 to 30) |
Positive nodes | 2 (1 to 4) | 3 (1 to 4) |
Grade | 3 (2 to 3) | 3 (2 to 3) |
NPI | 5.30 (4.50 to 5.61) | 5.21 (4.50 to 5.60) |
ER +ve | 202 (54.0%) | 158 (54.9%) |
ER -ve | 119 (31.8%) | 96 (33.3%) |
ER Unk | 53 (14.2%) | 34 (11.8%) |